TY - JOUR
T1 - Growth of lung function in children with sickle cell anemia
AU - Field, Joshua J.
AU - DeBaun, Michael R.
AU - Yan, Yan
AU - Strunk, Robert C.
PY - 2008/11
Y1 - 2008/11
N2 - Lung disease is a common cause of morbidity among children with sickle cell disease (SCD). Although cross-sectional studies of children with SCD describe abnormal pulmonary function, the pattern of lung function growth in these children compared to children in the general population is not known. To provide preliminary evidence that growth of lung function is attenuated in children with SCD, we conducted a retrospective cohort study of children with hemoglobin SS (HbSS) ages 6-19 years who received at least two spirometry assessments for clinical care. The growth of lung function in these cases was compared to age, gender, and race-specific children without SCD or respiratory complaints from the Harvard Six Cities Study (H6CS). Seventy-nine children with HbSS contributed 363 spirometry measurements (mean per child = 4.6, median = 4.0, range = 2-17) and 255 controls contributed 1,543 spirometry measurements (mean per child = 6.1, median = 6.0, range = 2-13). Longitudinal forced expiratory volume in 1 sec (FEV1) was lower for boys and girls with HbSS compared to children in the general population, P= 0.031 and P= 0.002, respectively. When compared to the H6CS cohort, girls with HbSS showed lower longitudinal forced vital capacity (FVC) (P < 0.001) and FEV1/FVC (0.038); there was no difference in FVC or FEV1/FVC between boys in the HbSS and H6CS cohort. We conclude that growth of lung function is reduced in children with HbSS compared to children in the general population. Gender may influence the risk of developing abnormal lung function and airway obstruction in children with HbSS. Pediatr Pulmonol. 2008; 43:1061-1066.
AB - Lung disease is a common cause of morbidity among children with sickle cell disease (SCD). Although cross-sectional studies of children with SCD describe abnormal pulmonary function, the pattern of lung function growth in these children compared to children in the general population is not known. To provide preliminary evidence that growth of lung function is attenuated in children with SCD, we conducted a retrospective cohort study of children with hemoglobin SS (HbSS) ages 6-19 years who received at least two spirometry assessments for clinical care. The growth of lung function in these cases was compared to age, gender, and race-specific children without SCD or respiratory complaints from the Harvard Six Cities Study (H6CS). Seventy-nine children with HbSS contributed 363 spirometry measurements (mean per child = 4.6, median = 4.0, range = 2-17) and 255 controls contributed 1,543 spirometry measurements (mean per child = 6.1, median = 6.0, range = 2-13). Longitudinal forced expiratory volume in 1 sec (FEV1) was lower for boys and girls with HbSS compared to children in the general population, P= 0.031 and P= 0.002, respectively. When compared to the H6CS cohort, girls with HbSS showed lower longitudinal forced vital capacity (FVC) (P < 0.001) and FEV1/FVC (0.038); there was no difference in FVC or FEV1/FVC between boys in the HbSS and H6CS cohort. We conclude that growth of lung function is reduced in children with HbSS compared to children in the general population. Gender may influence the risk of developing abnormal lung function and airway obstruction in children with HbSS. Pediatr Pulmonol. 2008; 43:1061-1066.
KW - Lung growth
KW - Pulmonary function tests
KW - Sickle cell disease
UR - http://www.scopus.com/inward/record.url?scp=57349179187&partnerID=8YFLogxK
U2 - 10.1002/ppul.20883
DO - 10.1002/ppul.20883
M3 - Article
C2 - 18972407
AN - SCOPUS:57349179187
SN - 8755-6863
VL - 43
SP - 1061
EP - 1066
JO - Pediatric Pulmonology
JF - Pediatric Pulmonology
IS - 11
ER -